Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Certara, Inc.

Certara ( ($CERT) ) has shared an update. On August 4, 2026, Certara, Inc. disclosed that its second quarter 2026 earnings call and related present...

Certara Corrects EBITDA Disclosure in Earnings Presentation

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Design Therapeutics (DSGN), Certara (CERT) and Gen...

Analysts Offer Insights on Healthcare Companies: Design Therapeutics (DSGN), Certara (CERT) and GeneDx Holdings (WGS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pediatrix Medical Group (MD), Certara (CERT) and G...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CERT	$8.20	+0.86%	2.23M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CERT	$8.20	+0.9%	2.23M
3
4
5
6

CERT

CERT

Get Certara, Inc. Data in Excel

Get Certara, Inc. Data in Excel